- You are viewing a Navigating Care library resource.
- Go to Library
To Learn More About Ovarian Germ Cell Tumors
For more information from the National Cancer Institute about ovarian germ cell tumors, see the following:
- Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Home Page
- Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
For general cancer information and other resources from the National Cancer Institute, visit:
- About Cancer
- Staging
- Chemotherapy and You: Support for People With Cancer
- Radiation Therapy and You: Support for People With Cancer
- Coping with Cancer
- Questions to Ask Your Doctor about Cancer
- For Survivors and Caregivers
This information is not intended to replace the advice of a doctor.
Navigating Care disclaims any liability for the decisions you make based on this information.
This information was sourced and adapted from Adapted from the National Cancer Institute's
Physician Data Query (PDQ®) Cancer Information Summaries on
www.cancer.gov.
This information updated
November 1, 2024.
Learn more:
- General Information About Ovarian Germ Cell Tumors
- Stages of Ovarian Germ Cell Tumors
- Treatment Option Overview
- Treatment of Stage I Ovarian Germ Cell Tumors
- Treatment of Stage II Ovarian Germ Cell Tumors
- Treatment of Stage III Ovarian Germ Cell Tumors
- Treatment of Stage IV Ovarian Germ Cell Tumors
- Treatment of Recurrent Ovarian Germ Cell Tumors
- To Learn More About Ovarian Germ Cell Tumors
Related Articles
- General Information About Ovarian Germ Cell Tumors
- Stages of Ovarian Germ Cell Tumors
- Treatment Option Overview
- Treatment of Stage I Ovarian Germ Cell Tumors
- Treatment of Stage II Ovarian Germ Cell Tumors
- Treatment of Stage III Ovarian Germ Cell Tumors
- Treatment of Stage IV Ovarian Germ Cell Tumors
- Treatment of Recurrent Ovarian Germ Cell Tumors
- To Learn More About Ovarian Germ Cell Tumors
See Expert Resources
The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.